— Know what they know.
Not Investment Advice

LNDC NASDAQ

Landec Corporation
1W: -3.0% 1M: +7.1% 3M: -24.2% 1Y: -7.9% 3Y: -19.5% 5Y: -28.5%
$8.76
Last traded 2022-11-14 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $263.6M mcap · 20M float · 0.327% daily turnover

Balance Sheet Trends

Total Assets
$239M +0.0% ▲
5Y CAGR: -14.3%
Total Liabilities
$192M +0.0% ▲
5Y CAGR: -5.1%
Shareholders Equity
$1M +0.0% ▲
5Y CAGR: -65.4%
Cash & Investments
$8M +0.0% ▲
5Y CAGR: +50.2%
Total Debt
$0 +0.0% ▲
Net Debt
-$8M +0.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2025
— Assets —
Cash$360K$1M$2M$3M$8M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$360K$1M$2M$3M$8M
Net Receivables$76M$70M$48M$31M$23M
Inventory$66M$70M$67M$42M$32M
Other Current Assets$14M$7M$7M$7M$22M
Total Current Assets$157M$148M$124M$83M$86M
Property, Plant & Equip.$218M$200M$139M$131M$129M
Goodwill & Intangibles$107M$106M$29M$14M$18M
Long-Term Investments$57M$45M$0$0$0
Other Non-Current Assets$2M$4M$3M$8M$7M
Total Non-Current Assets$384M$355M$171M$154M$154M
Total Assets$541M$503M$295M$237M$239M
— Liabilities —
Accounts Payable$52M$48M$16M$15M$8M
Short-Term Debt$93M$33M$46M$1M$0
Deferred Revenue$352K$1M$919K$3M$0
Other Current Liabilities$19M$20M$17M$19M$22M
Total Current Liabilities$164M$102M$79M$37M$30M
Long-Term Debt$128M$189M$10M$125M$0
Other Non-Current Liab.$18M$10M$98M$801K$162M
Total Non-Current Liabilities$146M$198M$108M$126M$162M
Total Liabilities$310M$300M$187M$163M$192M
— Equity —
Common Stock$29K$29K$30K$30K$37K
Retained Earnings$71M$39M-$59M-$139M-$205M
Accumulated OCI-$3M-$1M-$586K-$39M$0
Total Stockholders Equity$231M$203M$108M$35M$1M
Total Liabilities & Equity$541M$503M$295M$237M$193M
— Key Metrics —
Total Debt$221M$221M$153M$126M$0
Net Debt$221M$220M$152M$123M-$8M
Total Investments$57M$45M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms